

The calendar does not lie. Today is June 2nd, and the June 30th deadline for most mid-year CME budget cycles is approaching rapidly. If you are like many physician assistants, your employer-provided CME stipend reset is tied to the fiscal half-year, or you have 2026 funds that will expire if not allocated immediately.
At CME Review Courses, we understand the administrative pressure of clinical practice. You need to maintain your certification, secure your AAPA Category 1 credits, and maximize the value of your professional development funds without jumping through hoops.
Price: $399.99
Access: 30 Months
Deliverable: 100 Hours of AAPA Category 1 CME (PANRE Review)
Here are five clinical and administrative hacks to ensure you don’t leave a single dollar of your 2026 budget on the table.
1. Secure Your Entire 100-Hour Requirement in One Purchase
The most common mistake PAs make is "nickel-and-diming" their CME budget on small 1-hour or 2-hour modules. This creates an administrative nightmare when it comes time to log hours with the NCCPA.
By choosing the PANRE Review Course CME Package, you secure all 100 hours of AAPA Category 1 CME credit in a single transaction. This satisfies your entire two-year cycle requirement.
Hack: Purchase before June 30th to use your 2026 funds. Because you receive 30 months of access, you can buy the course now and complete the content at your own pace over the next two years.
2. Leverage the Gift Card Add-On for Educational Enrichment
Many clinicians are unaware that they can further enrich their educational experience by adding a gift card to their purchase. Our CME with Gift Card options allow you to add an Amazon or Apple Gift Card ranging from $100 to $1500 to your order.


Hack: Use the gift card to purchase the hardware or supplemental texts you need for your clinical practice. Whether it is a new iPad for viewing our Dermatology and Cardiology modules or a new set of clinical reference books, this is the most efficient way to use your remaining 2026 stipend before the June 30th cutoff.
3. Prioritize Pharmacology Credits Early
If you are a nurse practitioner or a PA in a state with specific pharmacology requirements, the Pharmacology Course is essential. While the PANRE Review offers 100 hours of Category 1 credit, our targeted pharmacology content ensures you meet the stringent requirements for prescriptive authority.
Hack: Do not wait until December to find out you are short on "Pharm" hours. Using your 2026 budget now ensures you are compliant for the rest of the year. Our content covers high-yield topics in Cardiology, Neurology, and Internal Medicine, providing immediate clinical utility.
4. Cross-Professional Credit Utilization
While our courses are written by physician assistants for physician assistants, they provide significant value to the entire healthcare team.
- Nurse Practitioners: AAPA Category 1 credit is accepted by the ANCC for NP certification renewal in many states.
- Physicians: While this counts as Category 2 CME for physicians, the clinical depth of our Emergency Medicine and Family Medicine packages makes it a popular choice for MDs and DOs looking to sharpen their diagnostic skills using their departmental budget.
5. Beat the Mid-Year Price Adjustments
As the NCCPA Blueprint evolves and new clinical guidelines are released, course content is updated. By purchasing your PANRE/PANRE-LA Review before June 30th, you lock in current pricing and 30 months of access to the most up-to-date high-yield content in Orthopedics, Psychiatry, and OB/GYN.


Clinical Practice Challenge
To ensure you are ready for your next shift (or the PANRE), review the following clinical vignettes.
Scenario 1: Cardiology
Your patient is a 64-year-old male presenting to the emergency department with acute onset of "tearing" chest pain radiating to the back.
Vitals: BP 190/110 mmHg (right arm), 165/95 mmHg (left arm), HR 105 bpm, SaO2 96% on room air.
Physical Exam: A new grade II/VI diastolic murmur is heard at the right sternal border.
Question: What is the most appropriate initial diagnostic imaging study for this patient?
A. Chest X-ray
B. Transthoracic Echocardiogram (TTE)
C. Computed Tomography Angiography (CTA) of the chest and abdomen
D. Magnetic Resonance Angiography (MRA)
Answer: C. Computed Tomography Angiography (CTA) of the chest and abdomen.
In a stable patient with suspected aortic dissection, CTA is the gold standard due to its high sensitivity and ability to delineate the extent of the dissection. While a Chest X-ray (A) may show a widened mediastinum, it is not diagnostic. TTE (B) lacks the sensitivity of CTA for the descending aorta. MRA (D) is time-consuming and often inappropriate in an acute setting.
Scenario 2: Dermatology
Your patient is a 28-year-old female presenting with a pruritic rash on her wrists and between her fingers. She notes the itching is significantly worse at night.
Physical Exam: Small, linear, erythematous burrows are noted in the interdigital webs.
Question: What is the first-line pharmacological treatment for this condition?
A. Triamcinolone 0.1% cream
B. Permethrin 5% cream
C. Oral Fluconazole
D. Hydrocortisone 1% cream
Answer: B. Permethrin 5% cream.
The clinical presentation is classic for Scabies. Permethrin 5% cream is the first-line treatment and should be applied from the neck down and washed off after 8-14 hours. Topical steroids (A, D) will not treat the underlying infestation and may worsen the condition. Fluconazole (C) is an antifungal and is ineffective against mites.
Scenario 3: Internal Medicine
Your patient is a 52-year-old male with a history of type 2 diabetes mellitus and hypertension. His current A1c is 8.4% despite adherence to Metformin 1000mg BID. He has a BMI of 34.
Question: Which class of medication would be the most beneficial next step to improve glycemic control and provide cardiovascular protection?
A. Sulfonylureas
B. GLP-1 Receptor Agonists
C. DPP-4 Inhibitors
D. Meglitinides
Answer: B. GLP-1 Receptor Agonists.
GLP-1 receptor agonists (such as Liraglutide or Semaglutide) are preferred as second-line agents for patients with T2DM who have established atherosclerotic cardiovascular disease or are at high risk. They also assist with weight loss, which is beneficial given the patient's BMI. Sulfonylureas (A) carry a high risk of hypoglycemia and weight gain. DPP-4 inhibitors (C) and Meglitinides (D) do not offer the same cardiovascular benefits.
Don't Let Your Budget Expire
The June 30th deadline is a hard cutoff for many organizations. Secure your 100 hours of AAPA Category 1 CME today and take advantage of our gift card add-ons to enhance your clinical toolkit.








































